New study tests if personalized cholesterol targets beat standard statins for seniors with diabetes
Disease control
Recruiting now
This study is testing whether a personalized approach to lowering 'bad' cholesterol (LDL-C) works better than standard moderate-dose statins for preventing first heart attacks, strokes, or related events in people aged 70 and older with type 2 diabetes. About 2,186 participants w…
Phase: NA • Sponsor: Sin Gon Kim • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC